Serveur d'exploration sur la rapamycine et les champignons

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitor.

Identifieur interne : 000157 ( Main/Exploration ); précédent : 000156; suivant : 000158

A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitor.

Auteurs : Alienor Xhaard [France] ; Manon Launay [France] ; Flore Sicre De Fontbrune [France] ; David Michonneau [France] ; Aurelien Sutra Del Galy [France] ; Tereza Coman [France] ; Simona Pagliuca [France] ; Nathalie Dhedin [France] ; Marie Robin [France] ; Regis Peffault De Latour [France] ; Gerard Socie [France]

Source :

RBID : pubmed:31413313

Abstract

Acute graft-versus-host disease (aGVHD) remains one of the leading causes of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. No consensus exists on the best second-line treatment of steroid-refractory acute GVHD (SR-aGVHD). Previously published smaller studies on the use of sirolimus in SR-aGVHD treatment report a response rate of 57 to 86%, with 40% overall survival. The association of tacrolimus and mTOR inhibitor is supported by pre-clinical data and has been used as GVHD prophylaxis. We report 42 patients who received tacrolimus and mTOR inhibitor as a second- or third-line treatment of SR-aGVHD. Thirty-one patients were treated in second-line, with an overall response rate of 48.5% (complete response: 42%). Eleven patients were treated in third-line, with an overall response rate of 27%. Thirty-eight patients had at least one episode of infection, due to bacteria, viruses, fungi and parasites in 61, 42, 12 and two episodes, respectively. For patients treated in second-line, six-month and one-year survival were 61% and 42%, respectively. None of the patients treated in third-line survived. These results were not promising enough to initiate a phase three randomized clinical trial, but tacrolimus and mTOR inhibitor can be discussed among other options for patients with SR-aGVHD.

DOI: 10.1038/s41409-019-0633-y
PubMed: 31413313


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitor.</title>
<author>
<name sortKey="Xhaard, Alienor" sort="Xhaard, Alienor" uniqKey="Xhaard A" first="Alienor" last="Xhaard">Alienor Xhaard</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France. alienor.xhaard@aphp.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Launay, Manon" sort="Launay, Manon" uniqKey="Launay M" first="Manon" last="Launay">Manon Launay</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service de pharmacologie, Hôpital Européen Georges-Pompidou, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de pharmacologie, Hôpital Européen Georges-Pompidou, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sicre De Fontbrune, Flore" sort="Sicre De Fontbrune, Flore" uniqKey="Sicre De Fontbrune F" first="Flore" last="Sicre De Fontbrune">Flore Sicre De Fontbrune</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Michonneau, David" sort="Michonneau, David" uniqKey="Michonneau D" first="David" last="Michonneau">David Michonneau</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sutra Del Galy, Aurelien" sort="Sutra Del Galy, Aurelien" uniqKey="Sutra Del Galy A" first="Aurelien" last="Sutra Del Galy">Aurelien Sutra Del Galy</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Coman, Tereza" sort="Coman, Tereza" uniqKey="Coman T" first="Tereza" last="Coman">Tereza Coman</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Pagliuca, Simona" sort="Pagliuca, Simona" uniqKey="Pagliuca S" first="Simona" last="Pagliuca">Simona Pagliuca</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Dhedin, Nathalie" sort="Dhedin, Nathalie" uniqKey="Dhedin N" first="Nathalie" last="Dhedin">Nathalie Dhedin</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie adolescents-jeunes adultes, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie adolescents-jeunes adultes, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Robin, Marie" sort="Robin, Marie" uniqKey="Robin M" first="Marie" last="Robin">Marie Robin</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Peffault De Latour, Regis" sort="Peffault De Latour, Regis" uniqKey="Peffault De Latour R" first="Regis" last="Peffault De Latour">Regis Peffault De Latour</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Socie, Gerard" sort="Socie, Gerard" uniqKey="Socie G" first="Gerard" last="Socie">Gerard Socie</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Inserm UMR1160, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm UMR1160, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:31413313</idno>
<idno type="pmid">31413313</idno>
<idno type="doi">10.1038/s41409-019-0633-y</idno>
<idno type="wicri:Area/Main/Corpus">000208</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000208</idno>
<idno type="wicri:Area/Main/Curation">000208</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000208</idno>
<idno type="wicri:Area/Main/Exploration">000208</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitor.</title>
<author>
<name sortKey="Xhaard, Alienor" sort="Xhaard, Alienor" uniqKey="Xhaard A" first="Alienor" last="Xhaard">Alienor Xhaard</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France. alienor.xhaard@aphp.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Launay, Manon" sort="Launay, Manon" uniqKey="Launay M" first="Manon" last="Launay">Manon Launay</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service de pharmacologie, Hôpital Européen Georges-Pompidou, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de pharmacologie, Hôpital Européen Georges-Pompidou, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sicre De Fontbrune, Flore" sort="Sicre De Fontbrune, Flore" uniqKey="Sicre De Fontbrune F" first="Flore" last="Sicre De Fontbrune">Flore Sicre De Fontbrune</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Michonneau, David" sort="Michonneau, David" uniqKey="Michonneau D" first="David" last="Michonneau">David Michonneau</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sutra Del Galy, Aurelien" sort="Sutra Del Galy, Aurelien" uniqKey="Sutra Del Galy A" first="Aurelien" last="Sutra Del Galy">Aurelien Sutra Del Galy</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Coman, Tereza" sort="Coman, Tereza" uniqKey="Coman T" first="Tereza" last="Coman">Tereza Coman</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Pagliuca, Simona" sort="Pagliuca, Simona" uniqKey="Pagliuca S" first="Simona" last="Pagliuca">Simona Pagliuca</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Dhedin, Nathalie" sort="Dhedin, Nathalie" uniqKey="Dhedin N" first="Nathalie" last="Dhedin">Nathalie Dhedin</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie adolescents-jeunes adultes, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie adolescents-jeunes adultes, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Robin, Marie" sort="Robin, Marie" uniqKey="Robin M" first="Marie" last="Robin">Marie Robin</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Peffault De Latour, Regis" sort="Peffault De Latour, Regis" uniqKey="Peffault De Latour R" first="Regis" last="Peffault De Latour">Regis Peffault De Latour</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Socie, Gerard" sort="Socie, Gerard" uniqKey="Socie G" first="Gerard" last="Socie">Gerard Socie</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Inserm UMR1160, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm UMR1160, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Bone marrow transplantation</title>
<idno type="eISSN">1476-5365</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Acute graft-versus-host disease (aGVHD) remains one of the leading causes of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. No consensus exists on the best second-line treatment of steroid-refractory acute GVHD (SR-aGVHD). Previously published smaller studies on the use of sirolimus in SR-aGVHD treatment report a response rate of 57 to 86%, with 40% overall survival. The association of tacrolimus and mTOR inhibitor is supported by pre-clinical data and has been used as GVHD prophylaxis. We report 42 patients who received tacrolimus and mTOR inhibitor as a second- or third-line treatment of SR-aGVHD. Thirty-one patients were treated in second-line, with an overall response rate of 48.5% (complete response: 42%). Eleven patients were treated in third-line, with an overall response rate of 27%. Thirty-eight patients had at least one episode of infection, due to bacteria, viruses, fungi and parasites in 61, 42, 12 and two episodes, respectively. For patients treated in second-line, six-month and one-year survival were 61% and 42%, respectively. None of the patients treated in third-line survived. These results were not promising enough to initiate a phase three randomized clinical trial, but tacrolimus and mTOR inhibitor can be discussed among other options for patients with SR-aGVHD.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="In-Process" Owner="NLM">
<PMID Version="1">31413313</PMID>
<DateRevised>
<Year>2020</Year>
<Month>08</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1476-5365</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>55</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2020</Year>
<Month>01</Month>
</PubDate>
</JournalIssue>
<Title>Bone marrow transplantation</Title>
<ISOAbbreviation>Bone Marrow Transplant</ISOAbbreviation>
</Journal>
<ArticleTitle>A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitor.</ArticleTitle>
<Pagination>
<MedlinePgn>86-92</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/s41409-019-0633-y</ELocationID>
<Abstract>
<AbstractText>Acute graft-versus-host disease (aGVHD) remains one of the leading causes of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. No consensus exists on the best second-line treatment of steroid-refractory acute GVHD (SR-aGVHD). Previously published smaller studies on the use of sirolimus in SR-aGVHD treatment report a response rate of 57 to 86%, with 40% overall survival. The association of tacrolimus and mTOR inhibitor is supported by pre-clinical data and has been used as GVHD prophylaxis. We report 42 patients who received tacrolimus and mTOR inhibitor as a second- or third-line treatment of SR-aGVHD. Thirty-one patients were treated in second-line, with an overall response rate of 48.5% (complete response: 42%). Eleven patients were treated in third-line, with an overall response rate of 27%. Thirty-eight patients had at least one episode of infection, due to bacteria, viruses, fungi and parasites in 61, 42, 12 and two episodes, respectively. For patients treated in second-line, six-month and one-year survival were 61% and 42%, respectively. None of the patients treated in third-line survived. These results were not promising enough to initiate a phase three randomized clinical trial, but tacrolimus and mTOR inhibitor can be discussed among other options for patients with SR-aGVHD.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Xhaard</LastName>
<ForeName>Alienor</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-4449-989X</Identifier>
<AffiliationInfo>
<Affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France. alienor.xhaard@aphp.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Launay</LastName>
<ForeName>Manon</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Service de pharmacologie, Hôpital Européen Georges-Pompidou, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sicre de Fontbrune</LastName>
<ForeName>Flore</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Michonneau</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0003-4553-3065</Identifier>
<AffiliationInfo>
<Affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sutra Del Galy</LastName>
<ForeName>Aurelien</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-4716-1472</Identifier>
<AffiliationInfo>
<Affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Coman</LastName>
<ForeName>Tereza</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pagliuca</LastName>
<ForeName>Simona</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dhedin</LastName>
<ForeName>Nathalie</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Service d'hématologie adolescents-jeunes adultes, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Robin</LastName>
<ForeName>Marie</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peffault de Latour</LastName>
<ForeName>Regis</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Socie</LastName>
<ForeName>Gerard</ForeName>
<Initials>G</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-2114-7533</Identifier>
<AffiliationInfo>
<Affiliation>Service d'hématologie-greffe, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Inserm UMR1160, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2019</Year>
<Month>08</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Bone Marrow Transplant</MedlineTA>
<NlmUniqueID>8702459</NlmUniqueID>
<ISSNLinking>0268-3369</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2019</Year>
<Month>01</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2019</Year>
<Month>06</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2019</Year>
<Month>06</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2019</Year>
<Month>8</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>8</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2019</Year>
<Month>8</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">31413313</ArticleId>
<ArticleId IdType="doi">10.1038/s41409-019-0633-y</ArticleId>
<ArticleId IdType="pii">10.1038/s41409-019-0633-y</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Île-de-France</li>
</region>
<settlement>
<li>Paris</li>
</settlement>
</list>
<tree>
<country name="France">
<region name="Île-de-France">
<name sortKey="Xhaard, Alienor" sort="Xhaard, Alienor" uniqKey="Xhaard A" first="Alienor" last="Xhaard">Alienor Xhaard</name>
</region>
<name sortKey="Coman, Tereza" sort="Coman, Tereza" uniqKey="Coman T" first="Tereza" last="Coman">Tereza Coman</name>
<name sortKey="Dhedin, Nathalie" sort="Dhedin, Nathalie" uniqKey="Dhedin N" first="Nathalie" last="Dhedin">Nathalie Dhedin</name>
<name sortKey="Launay, Manon" sort="Launay, Manon" uniqKey="Launay M" first="Manon" last="Launay">Manon Launay</name>
<name sortKey="Michonneau, David" sort="Michonneau, David" uniqKey="Michonneau D" first="David" last="Michonneau">David Michonneau</name>
<name sortKey="Pagliuca, Simona" sort="Pagliuca, Simona" uniqKey="Pagliuca S" first="Simona" last="Pagliuca">Simona Pagliuca</name>
<name sortKey="Peffault De Latour, Regis" sort="Peffault De Latour, Regis" uniqKey="Peffault De Latour R" first="Regis" last="Peffault De Latour">Regis Peffault De Latour</name>
<name sortKey="Robin, Marie" sort="Robin, Marie" uniqKey="Robin M" first="Marie" last="Robin">Marie Robin</name>
<name sortKey="Sicre De Fontbrune, Flore" sort="Sicre De Fontbrune, Flore" uniqKey="Sicre De Fontbrune F" first="Flore" last="Sicre De Fontbrune">Flore Sicre De Fontbrune</name>
<name sortKey="Socie, Gerard" sort="Socie, Gerard" uniqKey="Socie G" first="Gerard" last="Socie">Gerard Socie</name>
<name sortKey="Socie, Gerard" sort="Socie, Gerard" uniqKey="Socie G" first="Gerard" last="Socie">Gerard Socie</name>
<name sortKey="Sutra Del Galy, Aurelien" sort="Sutra Del Galy, Aurelien" uniqKey="Sutra Del Galy A" first="Aurelien" last="Sutra Del Galy">Aurelien Sutra Del Galy</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000157 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000157 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:31413313
   |texte=   A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitor.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:31413313" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020